Jupiter Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-64,743
Closed -$7.94M 479
2022
Q3
$7.94M Sell
64,743
-15,902
-20% -$2.09M 0.12% 197
2022
Q2
$10.7M Sell
80,645
-15,565
-16% -$2.12M 0.15% 174
2022
Q1
$13.2M Sell
96,210
-80,368
-46% -$11.2M 0.16% 173
2021
Q4
$30.3M Buy
+176,578
New +$26.9M 0.33% 99
2020
Q4
Sell
-64,624
Closed -$7.4M 604
2020
Q3
$7.4M Buy
+64,624
New +$7.64M 0.08% 255

Other funds holding DGX

Jupiter Asset Management's DGX Position: Q4 2022 in Review

Jupiter Asset Management sold out of Quest Diagnostics (DGX) in Q4 2022, closing a stake of 64,743 shares — an estimated $7.94M sold.

Jupiter Asset Management first reported a position in DGX in Q3 2020 and held it in 5 quarters. The position peaked at $30.3M in Q4 2021. 879 funds tracked by Wall St. Rank hold DGX as of Q4 2022.

  • Jupiter Asset Management reported no remaining Quest Diagnostics position as of Q4 2022 after selling out during the quarter.
  • Jupiter Asset Management sold 64,743 Quest Diagnostics shares in Q4 2022, an estimated $7.94M.
  • Jupiter Asset Management first reported a position in Quest Diagnostics in Q3 2020 and held it in 5 quarters.
  • Jupiter Asset Management's Quest Diagnostics position peaked at $30.3M in Q4 2021.
  • 879 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.

Based on Jupiter Asset Management's 13F filing for Q4 2022, filed 10 Feb 2023.